Multiply Labs Raises $75M in Series B Funding to Expand Robotic Drug Manufacturing
Insider Brief Multiply Labs raised $75 million in Series B funding to expand its robotic systems for automating manual steps in biologics manufacturing. According to the San Francisco-based startup, Dr. Patrick Soon-Shiong and NantWorks led the round, with new investors AstraZeneca, Lingotto, Terad…
Read the full story at AI Insider ↗
Timeline · 1 report
- 2026-10-06 12:15 · AI Insider
Multiply Labs Raises $75M in Series B Funding to Expand Robotic Drug Manufacturing
More stories
- Mistral releases Mistral Large 4, dubbed "le Chonk", a 1T-parameter open-weight model for general agentic capabilities, trained on 4,000 Grace Blackwell GPUs (Sabrina Ortiz/The Deep View) — Techmeme
- Introducing GLM 5.3 on Amazon Bedrock — AWS Machine Learning Blog
- Sam Altman to Decoded: ‘The world should accept some bad things happening’ for the benefits of AI — Politico Technology
- OpenAI safety leader quits, warning AI company’s culture is ‘broken’ — The Guardian AI
- Trump’s big AI move: ‘Super Intelligence Force’ launched, Jay Clayton named AI czar — Mint AI
- can i run qwen flash next with these specs, or am i out of luck? — r/LocalLLM
- Supercharge regulated workloads with Claude Code and Amazon Bedrock — AWS Machine Learning Blog
- The Story of Qwen: Alibaba's AI Models From 7B to 2.4T — MarkTechPost
Get the daily brief of stories like this at 6:30 every morning →